FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2055789080> ?p ?o ?g. }

• W2055789080 endingPage "e317" @default.
• W2055789080 startingPage "e317" @default.
• W2055789080 abstract "In its first 8 years, the Global Programme to Eliminate Lymphatic Filariasis (GPELF) achieved an unprecedentedly rapid scale-up: >1.9 billion treatments with anti-filarial drugs (albendazole, ivermectin, and diethylcarbamazine) were provided via yearly mass drug administration (MDA) to a minimum of 570 million individuals living in 48 of the 83 initially identified LF-endemic countries.To assess the health impact that this massive global effort has had, we analyzed the benefits accrued first from preventing or stopping the progression of LF disease, and then from the broader anti-parasite effects ('beyond-LF' benefits) attributable to the use of albendazole and ivermectin. Projections were based on demographic and disease prevalence data from publications of the Population Reference Bureau, The World Bank, and the World Health Organization.Between 2000 and 2007, the GPELF prevented LF disease in an estimated 6.6 million newborns who would otherwise have acquired LF, thus averting in their lifetimes nearly 1.4 million cases of hydrocele, 800,000 cases of lymphedema and 4.4 million cases of subclinical disease. Similarly, 9.5 million individuals--previously infected but without overt manifestations of disease--were protected from developing hydrocele (6.0 million) or lymphedema (3.5 million). These LF-related benefits, by themselves, translate into 32 million DALYs (Disability Adjusted Life Years) averted. Ancillary, 'beyond-LF' benefits from the >1.9 billion treatments delivered by the GPELF were also enormous, especially because of the >310 million treatments to the children and women of childbearing age who received albendazole with/without ivermectin (effectively treating intestinal helminths, onchocerciasis, lice, scabies, and other conditions). These benefits can be described but remain difficult to quantify, largely because of the poorly defined epidemiology of these latter infections.The GPELF has earlier been described as a 'best buy' in global health; this present tally of attributable health benefits from its first 8 years strengthens this notion considerably." @default.
• W2055789080 created "2016-06-24" @default.
• W2055789080 creator A5035723806 @default.
• W2055789080 creator A5036676047 @default.
• W2055789080 creator A5047246603 @default.
• W2055789080 creator A5080199734 @default.
• W2055789080 date "2008-10-08" @default.
• W2055789080 modified "2023-10-05" @default.
• W2055789080 title "The Global Programme to Eliminate Lymphatic Filariasis: Health Impact after 8 Years" @default.
• W2055789080 cites W1508261324 @default.
• W2055789080 cites W155990156 @default.
• W2055789080 cites W1779401610 @default.
• W2055789080 cites W1820074434 @default.
• W2055789080 cites W1825104184 @default.
• W2055789080 cites W1927552400 @default.
• W2055789080 cites W1927985951 @default.
• W2055789080 cites W1944996554 @default.
• W2055789080 cites W1950738386 @default.
• W2055789080 cites W1955416682 @default.
• W2055789080 cites W1973149287 @default.
• W2055789080 cites W1973229615 @default.
• W2055789080 cites W1982435517 @default.
• W2055789080 cites W1989735647 @default.
• W2055789080 cites W1995121521 @default.
• W2055789080 cites W1996522356 @default.
• W2055789080 cites W1999706265 @default.
• W2055789080 cites W2023552484 @default.
• W2055789080 cites W2039128918 @default.
• W2055789080 cites W2042875107 @default.
• W2055789080 cites W2044514129 @default.
• W2055789080 cites W2056524740 @default.
• W2055789080 cites W2059495656 @default.
• W2055789080 cites W2082331911 @default.
• W2055789080 cites W2084782587 @default.
• W2055789080 cites W2084998898 @default.
• W2055789080 cites W2095237766 @default.
• W2055789080 cites W2098013497 @default.
• W2055789080 cites W2101382631 @default.
• W2055789080 cites W2103342806 @default.
• W2055789080 cites W2104972618 @default.
• W2055789080 cites W2112732565 @default.
• W2055789080 cites W2113491066 @default.
• W2055789080 cites W2123211752 @default.
• W2055789080 cites W2124806393 @default.
• W2055789080 cites W2132858060 @default.
• W2055789080 cites W2133006527 @default.
• W2055789080 cites W2141116761 @default.
• W2055789080 cites W2153435142 @default.
• W2055789080 cites W2157065916 @default.
• W2055789080 cites W2186307637 @default.
• W2055789080 cites W2398958539 @default.
• W2055789080 cites W308312594 @default.
• W2055789080 cites W3148794354 @default.
• W2055789080 cites W4291981365 @default.
• W2055789080 cites W2162857610 @default.
• W2055789080 doi "https://doi.org/10.1371/journal.pntd.0000317" @default.
• W2055789080 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2556399" @default.
• W2055789080 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18841205" @default.
• W2055789080 hasPublicationYear "2008" @default.
• W2055789080 type Work @default.
• W2055789080 sameAs 2055789080 @default.
• W2055789080 citedByCount "276" @default.
• W2055789080 countsByYear W20557890802012 @default.
• W2055789080 countsByYear W20557890802013 @default.
• W2055789080 countsByYear W20557890802014 @default.
• W2055789080 countsByYear W20557890802015 @default.
• W2055789080 countsByYear W20557890802016 @default.
• W2055789080 countsByYear W20557890802017 @default.
• W2055789080 countsByYear W20557890802018 @default.
• W2055789080 countsByYear W20557890802019 @default.
• W2055789080 countsByYear W20557890802020 @default.
• W2055789080 countsByYear W20557890802021 @default.
• W2055789080 countsByYear W20557890802022 @default.
• W2055789080 countsByYear W20557890802023 @default.
• W2055789080 crossrefType "journal-article" @default.
• W2055789080 hasAuthorship W2055789080A5035723806 @default.
• W2055789080 hasAuthorship W2055789080A5036676047 @default.
• W2055789080 hasAuthorship W2055789080A5047246603 @default.
• W2055789080 hasAuthorship W2055789080A5080199734 @default.
• W2055789080 hasBestOaLocation W20557890801 @default.
• W2055789080 hasConcept C141071460 @default.
• W2055789080 hasConcept C165901193 @default.
• W2055789080 hasConcept C203014093 @default.
• W2055789080 hasConcept C2776158911 @default.
• W2055789080 hasConcept C2777065887 @default.
• W2055789080 hasConcept C2777143589 @default.
• W2055789080 hasConcept C2777411658 @default.
• W2055789080 hasConcept C2777499811 @default.
• W2055789080 hasConcept C2777629521 @default.
• W2055789080 hasConcept C2780133432 @default.
• W2055789080 hasConcept C2780664029 @default.
• W2055789080 hasConcept C2908647359 @default.
• W2055789080 hasConcept C42972112 @default.
• W2055789080 hasConcept C71924100 @default.
• W2055789080 hasConcept C99454951 @default.
• W2055789080 hasConceptScore W2055789080C141071460 @default.
• W2055789080 hasConceptScore W2055789080C165901193 @default.
• W2055789080 hasConceptScore W2055789080C203014093 @default.

• next